MEDICAMEQ Stock Overview
Researches, develops, manufactures, markets, sells, and distributes pharmaceutical formulations and APIs in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Medicamen Biotech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹471.10 |
| 52 Week High | ₹845.00 |
| 52 Week Low | ₹355.45 |
| Beta | 1.36 |
| 11 Month Change | -9.47% |
| 3 Month Change | 23.13% |
| 1 Year Change | -32.89% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -14.66% |
Recent News & Updates
What Medicamen Biotech Limited's (NSE:MEDICAMEQ) 28% Share Price Gain Is Not Telling You
May 21
More Unpleasant Surprises Could Be In Store For Medicamen Biotech Limited's (NSE:MEDICAMEQ) Shares After Tumbling 26%
Mar 17Recent updates
What Medicamen Biotech Limited's (NSE:MEDICAMEQ) 28% Share Price Gain Is Not Telling You
May 21More Unpleasant Surprises Could Be In Store For Medicamen Biotech Limited's (NSE:MEDICAMEQ) Shares After Tumbling 26%
Mar 17Medicamen Biotech (NSE:MEDICAMEQ) Will Pay A Dividend Of ₹1.00
Sep 13Why Medicamen Biotech's (NSE:MEDICAMEQ) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 19There's Reason For Concern Over Medicamen Biotech Limited's (NSE:MEDICAMEQ) Price
Dec 03Shareholder Returns
| MEDICAMEQ | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.1% | -1.6% | 0.09% |
| 1Y | -32.9% | 49.1% | 46.1% |
Return vs Industry: MEDICAMEQ underperformed the Indian Pharmaceuticals industry which returned 49.1% over the past year.
Return vs Market: MEDICAMEQ underperformed the Indian Market which returned 46.1% over the past year.
Price Volatility
| MEDICAMEQ volatility | |
|---|---|
| MEDICAMEQ Average Weekly Movement | 9.4% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.6% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: MEDICAMEQ has not had significant price volatility in the past 3 months.
Volatility Over Time: MEDICAMEQ's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 388 | Rajesh Madan | medicamen.com/ |
Medicamen Biotech Limited researches, develops, manufactures, markets, sells, and distributes pharmaceutical formulations and APIs in India. The company offers a range of products, including tablets, such as non-beta lactam tablets; capsules comprising beta and non-beta lactam capsules; liquid and dry syrups; and ointments and creams. It also provides oral solid and liquid products.
Medicamen Biotech Limited Fundamentals Summary
| MEDICAMEQ fundamental statistics | |
|---|---|
| Market cap | ₹6.00b |
| Earnings (TTM) | ₹109.31m |
| Revenue (TTM) | ₹1.79b |
54.9x
P/E Ratio3.3x
P/S RatioIs MEDICAMEQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDICAMEQ income statement (TTM) | |
|---|---|
| Revenue | ₹1.79b |
| Cost of Revenue | ₹925.98m |
| Gross Profit | ₹867.09m |
| Other Expenses | ₹757.78m |
| Earnings | ₹109.31m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.60 |
| Gross Margin | 48.36% |
| Net Profit Margin | 6.10% |
| Debt/Equity Ratio | 15.4% |
How did MEDICAMEQ perform over the long term?
See historical performance and comparison